EL7.AI
BondsMedium•17 November 2026•
4 min read

Braskem Shares Close at $0.9721 as Debt Restructuring Talks Continue

Key Facts

1BAK shares closed at $0.9721 on November 16, 2026, versus $1.13 on November 13.
2The plan concerns the reorganization of about $11 billion in debt, with a court deadline of November 22, 2026.
3Reports cited by Braskem said bondholders rejected a proposal to convert $3.8 billion of debt into equity, while negotiations continue without a final decision.
4Cash and cash equivalents totaled 6,010 million Brazilian reais on September 30, 2026, versus 10,501 million reais on December 31, 2025.
5The company posted a consolidated net loss of 1,195 million Brazilian reais in the third quarter of 2026, versus 174 million reais in the same period of 2025.

Braskem shares, trading under the ticker BAK, closed at $0.9721 on November 16, 2026, down from a November 13 close of $1.13, according to EL7 data. The close came as the company said out-of-court restructuring negotiations were still ongoing and that exchanged proposals were indicative and non-binding. In a filing with the U.S. Securities and Exchange Commission, Braskem cited reports that bondholders had rejected a proposal to convert $3.8 billion of debt into equity. But in the same filing, it said negotiations were continuing and no final decision had been made. The session's share move therefore came amid unresolved negotiations, while the close alone does not establish that reports of the rejection caused the move.

The negotiations concern an out-of-court reorganization plan covering about $11 billion in debt, according to a Braskem filing responding to an inquiry from B3. The company set November 22, 2026, as the deadline for the reorganization process, with an approved debt plan to be submitted before then. It warned that missing the deadline could lead to a court-supervised reorganization. That leaves the parties facing a near-term deadline to settle the commercial terms, after Braskem said the latest extension made November 12 the target date for reaching an initial agreement. It said November 11 was not counted as a business day for purposes of the plan, making November 12 the revised date in the filing.

The company presented its main commercial terms for the updated plan on October 23, and investors submitted their proposal on October 24. Braskem's proposal included a $2.25 billion capital increase, of which $1.2 billion was guaranteed by major shareholders or other parties, alongside an immediate $2.8 billion debt-to-equity conversion upon completion of the transaction. Investors proposed a capital increase of the same total amount, with a $1.85 billion underwriting commitment and an immediate $1.85 billion debt-to-equity conversion. Braskem said in an October 24 filing that neither proposal had been accepted at that point. The terms of the two offers show differences in the size of the immediate debt conversion and the amount of the capital increase backed by an underwriting commitment.

On the creditors' side, Braskem said unsecured creditors that signed the plan represented 39.6% of claims subject to it. In a November 10 filing, the company said the exchanged proposals remained indicative and non-binding, and that management would assess appropriate steps if restructuring terms could not be agreed by the specified deadline. The company cited reports that bondholders had rejected a proposal to convert $3.8 billion of debt into equity, but stressed that negotiations were continuing and no final decision had been made. It also said shareholders had decided to withdraw their commitment to inject capital after bondholders rejected the proposal. The company thus reiterated court-supervised reorganization as one of the available alternatives.

Interim statements show the group's cash and cash equivalents fell to 6,010 million Brazilian reais on September 30, 2026, from 10,501 million reais on December 31, 2025. Braskem posted a consolidated net loss of 1,195 million Brazilian reais in the third quarter of 2026, compared with a loss of 174 million reais in the same quarter of 2025. These figures place liquidity and funding in the background of the restructuring the company is negotiating with creditors and shareholders. One published point of disagreement centers on how much debt would be converted into equity, as well as the size of new capital to be injected and the parties backing it. In its November 10 filing, the company gave no final decision on the terms, saying management would assess appropriate steps if the deadline passed without an agreement.

The latest commercial deadline set November 12 as the target date for an initial agreement, while the court deadline for completing the plan remained November 22. Braskem said negotiations were continuing and proposals were non-binding, and that management would assess appropriate steps if no agreement was reached before the specified deadline. Submission of an approved plan for about $11 billion in debt remains the court-mandated requirement cited by the company in its filing. If an agreement cannot be reached, missing the deadline could lead to a court-supervised reorganization, according to the filing submitted in response to a B3 inquiry. BAK's close at $0.9721 on November 16 records the latest documented price move as the outcome of negotiations remains unresolved.

Open on chart